【结 构 式】 |
【分子编号】17017 【品名】(2S)oxiranylmethyl butyrate 【CA登记号】 |
【 分 子 式 】C7H12O3 【 分 子 量 】144.17048 【元素组成】C 58.32% H 8.39% O 33.29% |
合成路线1
该中间体在本合成路线中的序号:(VI)The condensation of morpholine (I) with 3,4-difluoronitrobenzene (II) by means of diisopropylethylamine in refluxing acetonitrile gives 3-fluoro-4-(4-morpholinyl)nitrobenzene (III), which is reduced with ammonium formate over Pd/C in THF/methanol to the corresponding aniline (IV). The reaction of (IV) with benzyloxycarbonyl chloride and NaHCO3 in acetone/water yields the carbamate ester (V), which is cyclized with 2(R),3-epoxypropyl butyrate (VI) by means of butyllithium in THF affording 5(R)-(hydroxymethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]oxazolidin-2-one (VII). The reaction of (VII) with methanesulfonyl chloride and triethylamine in dichloromethane gives the mesylate (VIII), which by reaction with NaN3 in hot DMF is converted into the azide (IX). The reduction of (IX) with H2 over Pd/C in ethyl acetate affords the corresponding amine (X), which is finally acetylated with acetic anhydride and pyridine.
【1】 Brickner, S.J.; Hutchinson, D.K.; Barbachyn, M.R.; et al.; Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections. J Med Chem 1996, 39, 3, 673. |
【2】 Lizondo, J.; Rabasseda, X.; Castañer, J.; Linezolid. Drugs Fut 1996, 21, 11, 1116. |
【3】 Barbachyn, M.R.; Brickner, S.J.; Hutchinson, D.K. (Pharmacia Corp.); Substd. oxazine and thiazine oxazolidinone antimicrobials. EP 0717738; JP 1997502436; WO 9507271 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10388 | Morpholine | 110-91-8 | C4H9NO | 详情 | 详情 |
(II) | 17013 | 1,2-difluoro-4-nitrobenzene; 3,4-Difluoronitrobenzene | 369-34-6 | C6H3F2NO2 | 详情 | 详情 |
(III) | 17014 | 4-(2-fluoro-4-nitrophenyl)morpholine | C10H11FN2O3 | 详情 | 详情 | |
(IV) | 17015 | 3-fluoro-4-morpholinophenylamine; 3-fluoro-4-morpholinoaniline; 3-fluoro-4-(4-morpholinyl)phenylamine; 3-Fluoro-4-(4-morpholinyl)benzeneamine | 93246-53-8 | C10H13FN2O | 详情 | 详情 |
(V) | 17016 | benzyl N-(3-fluoro-4-morpholinophenyl)carbamate | C18H19FN2O3 | 详情 | 详情 | |
(VI) | 17017 | (2S)oxiranylmethyl butyrate | C7H12O3 | 详情 | 详情 | |
(VII) | 17018 | (5R)-3-(3-fluoro-4-morpholinophenyl)-5-(hydroxymethyl)-1,3-oxazolan-2-one | 168828-82-8 | C14H17FN2O4 | 详情 | 详情 |
(VIII) | 17019 | [(5R)-3-(3-fluoro-4-morpholinophenyl)-2-oxo-1,3-oxazolan-5-yl]methyl methanesulfonate | 174649-09-3 | C15H19FN2O6S | 详情 | 详情 |
(IX) | 17020 | (5R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)-1,3-oxazolan-2-one | C14H16FN5O3 | 详情 | 详情 | |
(X) | 17021 | (5S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)-1,3-oxazolan-2-one | C14H18FN3O3 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VI)The condensation of the protected 3,5-difluoroaniline (I) with 1-benzyl-4-piperidone (II) by means of BuLi in THF gives 4-(1-benzyl-4-hydroxypiperidin-4-yl)-3,5-difluoroaniline (III), which is dehydrated with refluxing conc. HCl to yield the tetrahydropyridine (IV). The reaction of (IV) with benzyl chloroformate in acetone/water affords the carbamate (V), which is cyclized with (R)-glycidyl butyrate (VI) by means of BuLi in THF to provide the oxazolidinone (VII). The condensation of (VII) with isoxazol-3-ol (VIII) by means of PPh3 and DIAD in THF gives the expected ether adduct (IX), which is debenzylated by reaction with 1-chloroethyl chloroformate in dichloromethane, yielding the free tetrahydropyridine derivative (X). The condensation of (X) with (S)-2,3-O-isopropylideneglyceric acid (XI) by means of DEC or DCC and TEA in dichloromethane affords the corresponding acyl tetrahydropyridine (XII), which is finally deprotected with HCl in THF to provide the target dihydroxy compound.
【1】 Gravestock, M.B. (AstraZeneca plc); Oxazolidinone derivs., process for their preparation and pharmaceutical compsns. containing them. EP 1082323; JP 2002517498; WO 9964417 . |
【2】 Gravestock, M.B.; Warren, K.E.H.; Ennis, D.S.; Currie, A.C.; Ainge, D. (AstraZeneca AB; AstraZeneca plc); Chemical processes and intermedies. WO 0140236 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 59481 | 1-(3,5-difluorophenyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine | C12H19F2NSi2 | 详情 | 详情 | |
(II) | 15720 | 1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one | 3612-20-2 | C12H15NO | 详情 | 详情 |
(III) | 59482 | 4-(4-amino-2,6-difluorophenyl)-1-benzyl-4-piperidinol | C18H20F2N2O | 详情 | 详情 | |
(IV) | 59483 | 4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenylamine; 4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluoroaniline | C18H18F2N2 | 详情 | 详情 | |
(V) | 59484 | benzyl 4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenylcarbamate | C26H24F2N2O2 | 详情 | 详情 | |
(VI) | 17017 | (2S)oxiranylmethyl butyrate | C7H12O3 | 详情 | 详情 | |
(VII) | 59485 | (5R)-3-[4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one | C22H22F2N2O3 | 详情 | 详情 | |
(VIII) | 59486 | 3-isoxazolol | C3H3NO2 | 详情 | 详情 | |
(IX) | 59487 | (5R)-3-[4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenyl]-5-[(3-isoxazolyloxy)methyl]-1,3-oxazolidin-2-one | C25H23F2N3O4 | 详情 | 详情 | |
(X) | 59488 | (5R)-3-[3,5-difluoro-4-(1,2,3,6-tetrahydro-4-pyridinyl)phenyl]-5-[(3-isoxazolyloxy)methyl]-1,3-oxazolidin-2-one | C18H17F2N3O4 | 详情 | 详情 | |
(XI) | 59489 | (4S)-2,2-dimethyl-1,3-dioxolane-4-carboxylic acid | C6H10O4 | 详情 | 详情 | |
(XII) | 59490 | (5R)-3-[4-(1-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]carbonyl}-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenyl]-5-[(3-isoxazolyloxy)methyl]-1,3-oxazolidin-2-one | C24H25F2N3O7 | 详情 | 详情 |